PUREGON

This brand name is authorized in Austria, Australia, Canada, Cyprus, Estonia, Spain, France, Hong Kong, Ireland, Israel, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, South Africa

Active ingredients

The drug PUREGON contains one active pharmaceutical ingredient (API):

1 Follitropin beta
UNII 076WHW89TW - FOLLITROPIN

Follitropin beta is a recombinant FSH. Follitropin beta can be used to stimulate follicular development and steroid production in selected cases of disturbed gonadal function. Furthermore follitropin beta can be used to promote multiple follicular development in medically assisted reproduction programs.

Read about Follitropin beta

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
PUREGON Solution for injection European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
G03GA06 Follitropin beta G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03G Gonadotropins and other ovulation stimulants → G03GA Gonadotropins
Discover more medicines within G03GA06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: AU Pharmaceutical Benefits Scheme Identifier(s): 6335K, 6336L, 6464F, 8565T, 8566W, 8871X
Country: CA Health Products and Food Branch Identifier(s): 02243948
Country: EE Ravimiamet Identifier(s): 1011913, 1011924, 1011935, 1064045, 1064056, 1064067, 1064078, 1064089, 1064090, 1099335, 1099403, 1209923, 1209934, 1209945, 1209956, 1209967, 1209978, 1209989, 1209990, 1210004, 1215100, 1215111
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 96008025, 96008038, 96008039, 96008041
Country: FR Base de données publique des médicaments Identifier(s): 60727755, 62448341, 65214799, 65393373
Country: HK Department of Health Drug Office Identifier(s): 51208, 51209, 55493
Country: IE Health Products Regulatory Authority Identifier(s): 88761, 88762, 88820, 88833
Country: IL מִשְׂרַד הַבְּרִיאוּת Identifier(s): 4733, 4734, 4965
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1007032, 1007033, 1007034, 1007035, 1007036, 1007037, 1007038, 1007039, 1007040, 1008120, 1008121, 1030534, 1030535, 1030536, 1030537, 1030538, 1030539, 1030540, 1030547, 1030548, 1030549, 1030550
Country: NL Z-Index G-Standaard Identifier(s): 14571420, 14571439, 15033163, 15294072, 15294080
Country: NL Z-Index G-Standaard, PRK Identifier(s): 64270, 64289, 77410, 84034, 84042
Country: NZ Medicines and Medical Devices Safety Authority Identifier(s): 8909
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100103866, 100103872, 100145712, 100145729, 100296500, 100313990, 100314008, 100314014, 100314020, 100314037
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W67765001, W67766001
Country: SG Health Sciences Authority Identifier(s): 12183P, 12184P, 12185P, 14473P, 14474P
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8683280337367, 8683280337374, 8699636791141
Country: ZA Health Products Regulatory Authority Identifier(s): 32/21.10/0311, 32/21.10/0312, 32/21.10/0313

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.